Aurinia Pharmaceuticals Inc (AUPH)

[CoolG73]

The EURORA trial enrollment was finished 2 months ahead of schedule with a 10% over enrolled. This is a good sign because it means they have quality patients. Also, Management used 27 countries out of the 31 planned ones, so this also bodes well since they would logically leave the more risky ones to the end.

These 2 points prove that Safety was much better maintained during this trial than it was during AURA ( where they didn't have the financial luxury to go with the best trial centers), hence I am expecting a drastic reduction in the Death rate.